Drug Safety Information for E.E.S. 400 (Erythromycin ethylsuccinate)

Safety-related Labeling Changes for E.E.S. (ERYTHROMYCIN ETHYLSUCCINATE) Brand name discontinued; available as generic: FDA Link

Adverse Drug Reactions for E.E.S. 400* (Erythromycin ethylsuccinate)

These charts and graphs are based on reports received through the FDA Adverse Event Reporting System (FAERS) program (see below).

Top 20 Adverse Effects Associated with E.E.S. 400
(reported in FDA Medwatch/FAERS Reports)

  Side Effect # of FDA Reports
3Drug hypersensitivity18
5Abdominal pain13
9Drug interaction12
11Aspartate aminotransferase increased11
12Drug ineffective10
13Weight decreased10
15Alanine aminotransferase increased10
17Burning sensation9

* This side effect also appears in "Top 10 Side Effects of E.E.S. 400 " in the drug's Review Summary based on AskaPatient reviews.

Top 10 Reasons for Taking E.E.S. 400
(associated with FDA Medwatch/FAERS Reports)

Reason # of FDA Reports
1Product used for unknown indication133
2Infected bites35
3Crohn's disease33
4Gastrointestinal motility disorder20
6Pneumonia mycoplasmal15
10Respiratory tract infection14

*Also a top-10 reason in AskaPatient Review Summary.

Types of Adverse Events for E.E.S. 400

Total Reports Filed with FDA: 1280

Number of FDA Adverse Event Reports by Patient Age for E.E.S. 400

Total Reports Filed with FDA: 1280*

* Reports for drugs with the same active ingredients have been aggregated in this analysis: Erythromycin ethylsuccinate (Wyamycin e, E-mycin e, Pediamycin, E.e.s., E.e.s, Ery-ped, Eryped 200, Eryped drops, Pediamycin 400, E.e.s. 200, Eryped 400, E.e.s. 400, Erythroped, Eryped)

Charts are based on 1280 reports filed with the FDA between 2004 and June 2015.

Adverse Event Reports are submitted to the FDA by pharmaceutical companies (mandatory reporting is required by manufacturers, distributors, or importers), health care providers such as doctors (voluntary reporting), and by patients themselves (voluntary reporting). More Information on FDA MedWatch (FDA Safety Information and Adverse Event Reporting Program)Voluntary reporting takes place under the FDA's MedWatch program, where health care professionals and consumers submit reports to FDA when they find a problem with a drug, medical device, biologic, or other FDA-regulated product. An adverse event is any undesirable experience or extreme side effect associated with the use of a medical product. Adverse events include: death, life threatening event, hospitalization, disability or permanent damage, congenital anomaly or birth defect, medical product use requiring a surgical or other intervention, or other serious medical situation believed to be caused by the drug.

Click to go back to search results and E.E.S. 400 Reviews and Review Summary .

Analytics of FDA Adverse Event Reports Provided by Druginformer.com. FDA Drug Safety Information, including safety-related labeling updates, required post-approval safety studies, risk evaluation management strategies (REMS), alerts, and recalls are compiled by AskaPatient.com from the U.S. Food and Drug Administration.

Visit   DrugInformer.com more on E.E.S. 400's side effects.